Cargando…
Selepressin and Arginine Vasopressin Do Not Display Cardiovascular Risk in Atherosclerotic Rabbit
BACKGROUND: Septic shock remains associated with significant mortality rates. Arginine vasopressin (AVP) and analogs with V(1A) receptor agonist activity are increasingly used to treat fluid-resistant vasodilatory hypotension, including catecholamine-refractory septic shock. Clinical studies have be...
Autores principales: | Boucheix, Olivier, Blakytny, Robert, Haroutunian, Gerard, Henriksson, Marie, Laporte, Regent, Milano, Stephane, Reinheimer, Torsten M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082805/ https://www.ncbi.nlm.nih.gov/pubmed/27788216 http://dx.doi.org/10.1371/journal.pone.0165422 |
Ejemplares similares
-
A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock*
por: He, Xinrong, et al.
Publicado: (2016) -
Selepressin, a novel selective vasopressin V(1A) agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients
por: Russell, James A., et al.
Publicado: (2017) -
Vasopressin in vasodilatory shock: is the heart in danger?
por: Hauser, Balázs, et al.
Publicado: (2008) -
Arginine Vasopressin and Copeptin in Perinatology
por: Evers, Katrina Suzanne, et al.
Publicado: (2016) -
Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury
por: Randesi, Matthew, et al.
Publicado: (2017)